These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16228182)

  • 21. Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism.
    Elliott E; Atlas R; Lange A; Ginzburg I
    Eur J Neurosci; 2005 Sep; 22(5):1081-9. PubMed ID: 16176349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.
    Noble W; Planel E; Zehr C; Olm V; Meyerson J; Suleman F; Gaynor K; Wang L; LaFrancois J; Feinstein B; Burns M; Krishnamurthy P; Wen Y; Bhat R; Lewis J; Dickson D; Duff K
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6990-5. PubMed ID: 15867159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
    Avila J
    FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy.
    Boimel M; Grigoriadis N; Lourbopoulos A; Touloumi O; Rosenmann D; Abramsky O; Rosenmann H
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):314-25. PubMed ID: 19225406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium treatment decreases activities of tau kinases in a murine model of senescence.
    Tajes M; Gutierrez-Cuesta J; Folch J; Ferrer I; Caballero B; Smith MA; Casadesus G; Camins A; Pallás M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):612-23. PubMed ID: 18520779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.
    Cowan CM; Chee F; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Apr; 38(2):564-70. PubMed ID: 20298222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
    Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
    J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
    J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model.
    Pérez M; Hernández F; Lim F; Díaz-Nido J; Avila J
    J Alzheimers Dis; 2003 Aug; 5(4):301-8. PubMed ID: 14624025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
    Yue M; Hanna A; Wilson J; Roder H; Janus C
    Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium treatment of APPSwDI/NOS2-/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype.
    Sudduth TL; Wilson JG; Everhart A; Colton CA; Wilcock DM
    PLoS One; 2012; 7(2):e31993. PubMed ID: 22347510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.
    Rockenstein E; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E
    BMC Neurosci; 2015 Nov; 16():85. PubMed ID: 26611895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.
    Julien C; Bretteville A; Planel E
    Methods Mol Biol; 2012; 849():473-91. PubMed ID: 22528110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model.
    Yoshiyama Y; Kojima A; Ishikawa C; Arai K
    J Alzheimers Dis; 2010; 22(1):295-306. PubMed ID: 20847440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.